Amalgamated Bank Acelrx Pharmaceuticals Inc Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$1.03 - $1.69 $13,577 - $22,277	-13,182 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$0.76 - $2.07 $190 - $517	-250 Reduced 1.86%	13,182 $16,000
Q4 2019 Feb 13, 2020	BUY	$1.66 - $2.4 $1,137 - $1,644	685 Added 5.37%	13,432 $28,000
Q3 2019 Nov 13, 2019	SELL	$2.1 - $2.87 $214 - $292	-102 Reduced 0.79%	12,747 $28,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.93 $26,982 - $50,496	12,849 New	12,849 $33,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.